TGTX TG Therapeutics, Inc.
$52.19 -3.19%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-3.19%
YTD
+43.00%
P/E
18.59
P/B
21.07
ROE
72.3%
Div yield
—
Beta
0.52
Market cap
$8.2B
RSI (14)
40
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$54.11
Close
$52.19
VWAP (n/a)
—
Day high
$54.11
Day low
$51.34
Volume
2.4M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share
Yahoo Finance · Sep 18
TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry
Yahoo Finance · Sep 16
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance · Sep 10
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
Yahoo Finance · Sep 3
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point
Yahoo Finance · Sep 2
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue?
Yahoo Finance · Sep 2
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 3, 2026 View → 8-K Jun 12, 2026 View → 8-K Jun 3, 2026 View → 8-K May 27, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell TGTX. Try it in the Lab to size a position and see the risk.